Showing 4381-4390 of 8129 results for "".
- Memantine May Improve Trichotillomania, Excoriation Disorderhttps://practicaldermatology.com/news/memantine-may-improve-trichotillomania-excoriation-disorder/2461594/The Alzheimer’s disease memantine effectively reduces symptoms of adults with trichotillomania and skin-picking disorder also known as excoriation disorder, new research shows. Researchers honed in on memantine based on earlier findings that revealed disorganized areas of white ma
- BTL Takes a Stand Against Illegal and Counterfeit Aesthetic Deviceshttps://practicaldermatology.com/news/btl-takes-a-stand-against-illegal-and-counterfeit-aesthetic-devices/2461593/BTL is making inroads in its efforts to safeguard medical providers and consumers from counterfeit devices in the United States through legal action and the seizure of illegally imported devices at the border. BTL has filed court documents stating that defendants use and sell knock
- U.S. FDA: Renuvion Cleared to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissuehttps://practicaldermatology.com/news/us-fda-renuvion-cleared-to-coagulate-and-contract-soft-tissues-including-subcutaneous-tissue/2461590/The U.S. Food and Drug Administration (FDA) has cleared the use of the Renuvion APR Handpiece for the delivery of radiofrequency energy and/or helium plasma where coagulation/contraction of soft tissue is needed. (Soft tissue includes subcutaneous tissue.) “We are pleas
- Merz Aesthetics Taps Christina Aguilera as New Xeomin Brand Partnerhttps://practicaldermatology.com/news/merz-aesthetics-taps-christina-aguilera-as-new-xeomin-brand-partner/2461588/Christina Aguilera is the latest Xeomin (incobotulinumtoxinA) brand partner as Merz Aesthetics expands its ‘Beauty on Your Terms’ marketing campaign. Launched in August 2022, the campaign features multiple music icons in support of Xeomin.
- Coral-friendly Sunscreen Provides Better UV Protection Than Existing Optionshttps://practicaldermatology.com/news/coral-friendly-sunscreen-provides-better-uv-protection-than-existing-options/2461584/A new coral-friendly polymeric UV filter may be more effective at preventing sunburn than existing sunscreens. Researchers used polymerization to create large molecules that still block UV radiation but are too big to penetrate our skin, coral, and algae. The study was p
- Baby Dove Launches #BabySkin Advice on TikTok with Top Dermatologists and Pediatricianshttps://practicaldermatology.com/news/baby-dove-launches-babyskin-advice-on-tiktok-with-top-dermatologists-and-pediatricians/2461582/Baby Dove is launching #BabySkin Advice,' on TikTok The series provides expert advice from dermatologists and pediatricians to help parents in search of trusted products to care for their newborns unique and delicate skin needs. The #BabySkin Advice series will run from&n
- Study: Plugging Immune Cell Leakage from Tumors Could Improve MelanomaTreatmenthttps://practicaldermatology.com/news/study-plugging-immune-cell-leakage-from-tumors-could-improve-melanomatreatment/2461578/The number of specialized immune cells available for fighting skin cancer double when a new treatment blocks their escape from melanoma tumors, according to new research out of NYU Langone Health’s Perlmutter Cancer Center Combining a chemical blocker of immune cell exit with
- Incyte Receives Positive CHMP Opinion for Opzelura Cream for the Treatment of Non-Segmental Vitiligohttps://practicaldermatology.com/news/incyte-receives-positive-chmp-opinion-for-opzelura-cream-for-the-treatment-of-non-segmental-vitiligo/2461576/The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of ruxolitinib cream (Opzelura) for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.
- Study: Psoriasis Medicine May Help Treat Alcohol Use Disorderhttps://practicaldermatology.com/news/psoriasis-medicine-may-help-treat-alcohol-use-diisorder/2461571/Apremilast may be an “incredibly promising” treatment for alcohol use disorder, according to a new study in the Journal of Clinical Investigation. On average, the people who took apremi
- Celluma Light Therapy Headquarters Moves to Tustin, Californiahttps://practicaldermatology.com/news/celluma-light-therapy-headquarters-moves-to-tustin-calif/2461570/BioPhotas, Inc., the maker of the Celluma Series of light therapy devices, is moving its corporate headquarters and manufacturing operations from Anaheim to Tustin, Calif. The new headquarters boasts 25,000 square feet of office and warehouse space, facilitating continued gro